Chapters: 00:00 Intro & Peter Magic Recap 03:52 Warrior Makers Event Update 05:23 Tesa, Ipamorelin & Histamine Reactions 11:24 Cloudy Peptides & Reconstitution Guide 18:59 Modafinil Benefits & Best Use Cases 23:40 Thyroid Meds, AOD & Fasting Protocols 26:44 Womens Hormones, Endometriosis & Tesa 30:48 Insomnia, Cortisol & Sleep Peptides 36:44 Dementia, Alzheimers & Brain Health Peptides 40:07 Pregnancy, Breastfeeding & Peptides 46:38 Cycling SLU-PP-332 & Growth Hormone Questions 55:02 Gut Health, Autoimmune Issues & Final Q&A We cover: Histamine Reactions to Tesamorelin & Ipamorelin: Why it happens, why injecting slower fixes it, and when to switch to Sermorelin or CJC instead Cloudy Peptides & Which Water to Use: Why nothing should ever be cloudy, the three peptides that need acetic acid water, and why room temp bacteriostatic water solves most problems Modafinil Overview: Why it's razor focus without the anxiety, why half a pill on an empty stomach is the sweet spot, and why it's non-habit forming Thyroid Meds, Fasting & Peptide Timing: Why you don't need to overthink spacing, what to avoid near T3, and which peptides actually require a fasted state Tesamorelin & IGF Peptides with Endometriosis & Fibroids: Why hormones must come first and why a knowledgeable doctor is essential before adding any growth peptides Sleep Stack for Postmenopausal Insomnia: DSIP, Epithalon, Sermorelin, C-Lonk, plus the supplement protocol that fixed JD's sleep magnesium glycinate, glycine, ashwagandha and slow-release melatonin Dementia & Alzheimer's Prevention: Why Dihexa, Pinealon and Cerebrolysin are the three to research and what the current studies are showing Cancer History & Peptide Safety: Why BPC-157 bypasses cancer cells, why secretagogues are the ones to avoid, and why NAD, MOTS-C, AOD and PT-141 are generally safe What Not to Stack Together: GHRHs, GHRPs, GLP-1s, Kisspeptin on TRT, Glow and GHK-CU separately, and Melanotan 1 vs
Negative effects are rare but may include: Mild discomfort at the injection site, temporary diarrhea, allergic reactions, or rash
GLP-1 receptor agonists are a novel class of pharmacological agents for obesity and T2D
Patients: 1864 adult patients with inadequately controlled type 2 diabetes (7.0%-10.5%) receiving metformin alone or metformin with a sulfonylurea were randomized to semaglutide tablets 14 mg (n=465), 7 mg (n=466), 3 mg (n=466), or Januvia 100 mg (n=467), all once daily
Hsieh et al., 2017)
